EUVIMEDEUVIMED entdecken
Crossref

Assessing the Persistence and Relevance of Small T‐ LGL Clones via TRBC1 in a Flowcytometric Lymphoid Screening Tube

Nathan Debunne iD, Barbara Cauwelier iD, Helena Devos, Sylvia Snauwaert, Jan Emmerechts

International Journal of Laboratory Hematology · 2025

DOI: 10.1111/ijlh.14525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2025. Verfasst von Nathan Debunne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Hematology, AZ Sint-Jan Hospital, Bruges, Belgium. Hauptthemen laut MEDLINE: Flow Cytometry, T-Lymphocytes, Receptors, Antigen, T-Cell, alpha-beta, Hematologic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Recently, monoclonal antibodies targeting one of the two mutually exclusive constant regions of the TCR β receptor chain (TRBC1 and TRBC2) have been proposed as a surrogate tool for assessing T‐cell clonality by flowcytometry. The detection of T‐cell clones is typically interpreted in the context of malignancy. However, small T‐cell clones of uncertain significance (T‐CUS) are frequently identified, posing diagnostic and clinical challenges. Since 2022, TRBC1 was incorporated as a marker for T‐cell clonality in our flowcytometric lymphoid screening tube (LST), a tube designed to detect both B‐ and T‐cell aberrancies in the blood of patients with clinical suspicion of hematological malignancy. The objective of the current study was to systematically evaluate the frequency and size of T‐cell clones identified at initial diagnosis and to evaluate clonal evolution in follow‐up samples.

Methods

In this single‐centre retrospective study (2022–2024), peripheral blood samples of 3495 unique patients were tested for T‐cell clonality using TRBC1. The monotypic T‐cell clones of > 50/μL were stratified into three groups: T‐CUS1 (50–500 monotypic cells/μL), T‐CUS2 (500–2000 monotypic cells/μL), and T‐LGL (> 2000 monotypic cells/μL). Follow‐up samples were obtained at least 6 months after initial testing (range: 6–30 months) and potential indicators of progression to T‐CUS2 or T‐LGL were evaluated.

Results

The majority of T‐CUS clones (22/36, 61%) were not detected (< 50 monotypic cells/μL) at follow‐up, thereby demonstrating the importance of evaluation of the persistance of small T‐cell clones. Fifteen percent of patients with a T‐CUS1 progressed to T‐CUS2, but none to T‐LGL (95% CI: 0%–15%). 22% (95% CI: 3%–60%) of T‐CUS2 patients evolved to T‐LGL, all of which showed aberrant expression of CD57. In the patient group who showed evolution to T‐CUS2 or T‐LGL, significantly lower hemoglobin levels and neutrophil counts were observed at the time of T‐CUS detection. Additionally, in this group, comparable increases in monotypic T‐cell clones were observed over time, with a main increment of 90 monotypic cells/μL per month (95% CI: 34%–145%).

Conclusions

The low number of persistence observed in T‐CUS at follow‐up highlights the need for cautious interpretation of small T‐cell clones (T‐CUS1). Low hemoglobin and neutrophil counts at diagnosis might indicate higher risk for progression and need for closer follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flow CytometryT-LymphocytesReceptors, Antigen, T-Cell, alpha-betaHematologic NeoplasmsHumansRetrospective StudiesMaleFemaleMiddle AgedClone CellsAdultAged

Stichwörter der Autor:innen

TRBC1T‐CUSchronic T‐cell lymphoproliferative diseasesflow cytometry

Substanzen

Receptors, Antigen, T-Cell, alpha-beta

Autor:innen und Institutionen

  • Laboratory of Hematology, AZ Sint-Jan Hospital, Bruges, Belgium.
  • Department of Hematology, AZ Sint-Jan Hospital, Bruges, Belgium.

ORCID-Profile: Nathan Debunne, Barbara Cauwelier

Zitieren

APA

Debunne, N., Cauwelier, B., Devos, H., Snauwaert, S., & Emmerechts, J. (2025). Assessing the Persistence and Relevance of Small T‐ LGL Clones via TRBC1 in a Flowcytometric Lymphoid Screening Tube. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14525

Vancouver

Debunne N, Cauwelier B, Devos H, Snauwaert S, Emmerechts J. Assessing the Persistence and Relevance of Small T‐ LGL Clones via TRBC1 in a Flowcytometric Lymphoid Screening Tube. International Journal of Laboratory Hematology. 2025. doi:10.1111/ijlh.14525

BibTeX
@article{Debunne2025,
  author = {Debunne, Nathan and Cauwelier, Barbara and Devos, Helena and Snauwaert, Sylvia and Emmerechts, Jan},
  title = {Assessing the Persistence and Relevance of Small T‐ LGL Clones via TRBC1 in a Flowcytometric Lymphoid Screening Tube},
  journal = {International Journal of Laboratory Hematology},
  year = {2025},
  doi = {10.1111/ijlh.14525}
}
Kostenlos starten →